BMED vs TMAT
iShares Health Innovation Active ETF vs Main Thematic Innovation ETF
Which is better, BMED or TMAT?
Each has led over a different period.
BMED has a lower expense ratio. BMED led over 1Y and the full window, TMAT over 3Y and 5Y. TMAT is less concentrated, with 30.3% of the fund in its ten largest positions against 42.3%.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | BMED | TMAT |
|---|---|---|
| Expense Ratio | 0.55%Best | 0.79% |
| AUM | $14M | $259M |
| Dividend Yield | 0.24% | 0.02% |
| Holdings | 61 | 168 |
| YTD Return | +13.90%Best | +12.58% |
| 1Y Return | +25.38%Best | +1.72% |
| 3Y Return (annualized) | +15.61% | +28.31%Best |
| 5Y Return (annualized) | +3.48% | +4.73%Best |
| Volatility (annualized) | 16.5%Best | 27.8% |
| Max Drawdown | -36.4%Best | -58.5% |
| $10,000 over 5 years | $11,865 | $12,600Best |
| Top 10 Weight | 42.3% | 30.3%Best |
| Fund Family | BlackRock, Inc. (US) | Main Management ETF Advisors, LLC |
| Category | Equity | Equity |
| Style | All Cap Blend | All Cap Blend |
| Inception | Sep 29, 2020 | Jan 28, 2021 |
Volatility and max drawdown are measured over the window both funds cover: Jan 29, 2021 to Oct 14, 2026 (5.7 years).
BMED vs TMAT growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 5.7 years both funds cover.
BMED vs TMAT Performance
iShares Health Innovation Active ETF (BMED) is an ETF from BlackRock, Inc. (US) and Main Thematic Innovation ETF (TMAT) is an ETF from Main Management ETF Advisors, LLC. Over the past year BMED returned +25.38% while TMAT returned +1.72%. Year to date, BMED is up 13.90% versus a gain of 12.58% for TMAT.
Over three years, BMED compounded at +15.61% per year against +28.31% for TMAT; over five years the annualized figures are +3.48% and +4.73% respectively. Across the full 6-year window we track, BMED has the edge at +2.67% annualized vs +2.59%.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
TMAT has been the more volatile fund, with annualized monthly volatility of 27.8% compared with 16.5% for BMED. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -36.4% for BMED and -58.5% for TMAT. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.58. They move together some of the time, and apart the rest.
Fees and Cost Over Time
BMED charges 0.55% per year while TMAT charges 0.79%. On a $10,000 position that is $55 vs $79 annually, a gap of $24 per year that compounds over a long holding period. On income, BMED currently yields 0.24% against 0.02% for TMAT.
Holdings Overlap
8.6% of BMED's money is in holdings TMAT also owns. 2.9% of TMAT's money is in holdings BMED also owns.
BMED and TMAT share little of their money.
4 positions in common, counted across the 53 positions we hold weights for in BMED and 85 in TMAT, against full books of 61 and 168.
What only one of them owns
Our book lists 73 positions for TMAT that do not appear in our book for BMED (87.2% of the fund), and 39 for BMED that do not appear in TMAT (78.8%).
Some of those will be the same company recorded under a different code in one of the two books, so the real difference in what you would own is no larger than this and may be smaller. We do not name the individual positions here for that reason.
You are not choosing between two funds in isolation.
Whichever of BMED and TMAT you pick has to sit alongside everything else you own. Add the rest and see what the combination actually holds.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, BMED or TMAT?
BMED has an expense ratio of 0.55% while TMAT charges 0.79%. BMED is the cheaper option, by $24 a year on a $10,000 investment.
Which performed better, BMED or TMAT?
Over the past year BMED returned +25.38% vs +1.72% for TMAT, so BMED leads on 1-year performance. Over the longest common window we track (6 years), BMED annualized +2.67% vs +2.59% for TMAT. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, BMED or TMAT?
TMAT has been the more volatile fund at 27.8% annualized versus 16.5% for BMED. Worst drawdown: BMED -36.4% vs TMAT -58.5%.
Should I hold both BMED and TMAT?
BMED and TMAT have a monthly-return correlation of 0.58, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
What is the holdings overlap between BMED and TMAT?
8.6% of BMED's money is in holdings TMAT also owns. 2.9% of TMAT's is in holdings BMED also owns. They hold 4 positions in common, counted across the 53 positions we hold weights for in BMED and 85 in TMAT.
Which pays a higher dividend, BMED or TMAT?
BMED yields 0.24% while TMAT yields 0.02%, so BMED currently pays the higher dividend yield.
Is TMAT better than BMED?
BMED has a lower expense ratio. BMED led over 1Y and the full window, TMAT over 3Y and 5Y. TMAT is less concentrated, with 30.3% of the fund in its ten largest positions against 42.3%. Which one suits a particular account depends on what it is for. This is information, not a recommendation.